References
- RL Prior, and X Wu. (2006). Anthocyanins: Structural characteristics that result in unique metabolic patterns and biological activities. Free Radic Res 40:1014–1028.
- YC Chang, KX Huang, AC Huang, YC Ho, and CJ Wang. (2006). Hibiscus anthocyanins-rich extract inhibited LDL oxidation and oxLDL-mediated macrophages apoptosis. Food Chem Toxicol 44:1015–1023.
- I Serraino, L Dugo, P Dugo, L Mondello, E Mazzon, G Dugo, AP Caputi, and S Cuzzocrea. (2003). Protective effects of cyanidin-3-O-glucoside from blackberry extract against peroxynitrite-induced endothelial dysfunction and vascular failure. Life Sci 73:1097–1114.
- PN Chen, SC Chu, HL Chiou, CL Chiang, SF Yang, and YS Hsieh. (2006). Cyanidin 3-glucoside and peonidin 3-glucoside inhibit tumor cell growth and induce apoptosis in vitro and suppress tumor growth in vivo. Nutr Cancer 53:232–243.
- D Ghosh, and T Konishi. (2007). Anthocyanins and anthocyanin-rich extracts: Role in diabetes and eye function. Asia Pac J Clin Nutr 16:200–208.
- GJ McDougall, D Stewart, GJ McDougall, and D Stewart. (2005). Biofactors 23:189–195.
- AD Baron. (1998). Postprandial hyperglycaemia and alpha-glucosidase inhibitors. Diabetes Res Clin Pract 40:S51–S55.
- JL Chiasson, RG Josse, R Gomis, M Hanefeld, A Karasik, and M Laakso. (2002). STOP-NIDDM trial research group. Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: Facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data. Lancet 359:2072–2077.
- R Tsao, R Yang, JC Young, and H Zhu. (2003). Polyphenolic profiles in eight apple cultivars using high-performance liquid chromatography (HPLC). J Agric Food Chem 51:6347–6353.
- X Yan, BT Murphy, GB Hammond, JA Vinson, and CC Neto. (2002). Antioxidant activities and antitumor screening of extracts from cranberry fruit (Vaccinium macrocarpon). J Agric Food Chem 50:5844–5849.
- B Jayaprakasam, SK Vareed, LK Olson, MG Nair, B Jayaprakasam, SK Vareed, LK Olson, and MG Nair. (2005). J Agric Food Chem 53:28–31.
- M Toda, J Kawabata, and T Kasai. (2000). Alpha-glucosidase inhibitors from clove (Syzgium aromaticum). Biosci Biotechnol Biochem 64:294–298.
- L Kandra, A Zajacz, J Remenyik, and G Gyemant. (2005). Kinetic investigation of a new inhibitor for human salivary alpha-amylase. Biochem Biophys Res Commun 334:824–828.
- CD Kay, G Mazza, BJ Holub, and J Wang. (2004). Anthocyanin metabolites in human urine and serum. Br J Nutr 91:933–942.
- Y Wang, L Ma, Z Li, Z Du, Z Liu, J Qin, X Wang, Z Huang, L Gu, and AS Chen. (2004). Synergetic inhibition of metal ions and genistein on alpha-glucosidase. FEBS Lett 576:46–50.
- DE Kelley, P Bidot, Z Freedman, B Haag, D Podlecki, M Rendell, D Schimel, S Weiss, T Taylor, A Krol, and J Magner. (1998). Efficacy and safety of acarbose in insulin-treated patients with type 2 diabetes. Diabetes Care 21:2056–2061.
- H Kentrup, H Bongers, M Spengler, G Kusenbach, and H Skopnik. (1999). Efficacy and safety of acarbose in patients with cystic fibrosis and impaired glucose tolerance. Eur J Pediatr 158:455–459.
- JA Balfour, and D McTavish. (1993). Acarbose. An update of its pharmacology and therapeutic use in diabetes mellitus. Drugs 46:1025–1054.
- R Coniff, and A Krol. (1997). Acarbose: A review of US clinical experience. Clin Ther 19:16–26.
- M Carrascosa, F Pascual, and S Aresti. (1997). Acarbose-induced acute severe hepatotoxicity. Lancet 349:698–699.
- D Mennecier, ES Zafrani, D Dhumeaux, and A Mallat. (1999). Acarbose-induced acute hepatitis. Gastroenterol Clin Biol 23:1398–1399.